GetTopicDetailResponse(id=b73c1114e24c, topicName=jakinib, introduction=jakinib, content=骨髓纖維化 II期臨床 jakinib, image=null, comments=0, allHits=1014, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Feb 24 10:25:24 CST 2024, time=2024-02-24, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=487299, tagList=[TagDto(tagId=487299, tagName=jakinib)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2189027, encodeId=f915218902ebb, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纖維化#</a> <a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期臨床#</a> <a href='/topic/show?id=b73c1114e24c' target=_blank style='color:#2F92EE;'>#jakinib#</a>, objectTitle=Am. J. Hematol | ZGJAK002臨床試驗(yàn)長期隨訪結(jié)果分析：Jakinib100mg BID和200mg QD兩種劑量在初治骨髓纖維化（MF）患者中的療效和安全性, objectType=article, longId=814488, objectId=ece88144885c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240223/1708698378759_6145188.jpg, objectUrl=/article/show_article.do?id=ece88144885c, replyNumber=0, likeNumber=135, createdTime=2024-02-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ece88144885c, moduleTitle=Am. J. Hematol | ZGJAK002臨床試驗(yàn)長期隨訪結(jié)果分析：Jakinib100mg BID和200mg QD兩種劑量在初治骨髓纖維化（MF）患者中的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ece88144885c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-02-24發(fā)表于上海
